Total Payments
$7,051
2024 Payments
$408.31
Companies
40
Transactions
331
Medicare Patients
6,920
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$5,516 (78.2%)
Education$1,037 (14.7%)
Other$498.50 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,516 | 313 | 78.2% |
| Education | $1,037 | 13 | 14.7% |
| Long term medical supply or device loan | $498.50 | 5 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,435 | 117 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,039 | 63 | $0 (2024) |
| PFIZER INC. | $510.22 | 32 | $0 (2024) |
| Genentech USA, Inc. | $509.20 | 33 | $0 (2023) |
| Incyte Corporation | $416.34 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $238.17 | 5 | $0 (2019) |
| Merck Sharp & Dohme LLC | $221.24 | 12 | $0 (2023) |
| Astellas Pharma US Inc | $182.13 | 6 | $0 (2019) |
| Shire North American Group Inc | $140.16 | 3 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $123.21 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $408.31 | 17 | Novartis Pharmaceuticals Corporation ($170.58) |
| 2023 | $867.44 | 31 | Novartis Pharmaceuticals Corporation ($470.18) |
| 2022 | $730.79 | 37 | Novartis Pharmaceuticals Corporation ($522.66) |
| 2021 | $699.97 | 37 | Novartis Pharmaceuticals Corporation ($228.83) |
| 2020 | $341.99 | 14 | Novartis Pharmaceuticals Corporation ($236.65) |
| 2019 | $1,266 | 53 | Astellas Pharma US Inc ($165.18) |
| 2018 | $1,202 | 58 | Novartis Pharmaceuticals Corporation ($238.34) |
| 2017 | $1,535 | 84 | Novartis Pharmaceuticals Corporation ($431.54) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
| 11/14/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Hematology | ||||||
| 11/01/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Oncology | ||||||
| 08/14/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: HEMATOLOGY | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $84.99 | General |
| 05/13/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Oncology | ||||||
| 04/15/2024 | Menarini Silicon Biosystems, Inc. | Cellsearch (Device) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: Diagnostics | ||||||
| 03/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Oncology | ||||||
| 03/07/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: Oncology | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Oncology | ||||||
| 12/18/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Oncology | ||||||
| 12/18/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Oncology | ||||||
| 12/14/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Oncology | ||||||
| 12/13/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Oncology | ||||||
| 12/13/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $1.96 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Oncology | ||||||
| 10/27/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $36.20 | General |
| Category: Hematology | ||||||
| 10/25/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,647 | 46,547 | $1.1M | $366,254 |
| 2022 | 13 | 1,801 | 39,288 | $879,529 | $265,761 |
| 2021 | 15 | 1,820 | 48,427 | $923,492 | $289,247 |
| 2020 | 16 | 1,652 | 51,142 | $988,823 | $341,668 |
Total Patients
6,920
Total Services
185,404
Medicare Billing
$1.3M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 5,640 | $214,320 | $104,564 | 48.8% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 43 | 36,400 | $291,200 | $85,846 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 741 | $259,350 | $85,506 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 405 | $101,250 | $30,932 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 79 | 158 | $43,450 | $11,441 | 26.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 402 | 1,360 | $34,000 | $10,325 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 390 | 1,160 | $23,200 | $9,712 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $26,100 | $8,154 | 31.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 49 | $24,500 | $5,778 | 23.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 77 | 332 | $16,600 | $4,295 | 25.9% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 18 | 41 | $15,580 | $3,519 | 22.6% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 14 | 14 | $12,810 | $2,377 | 18.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $7,975 | $1,619 | 20.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $4,235 | $1,132 | 26.7% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 12 | 24 | $2,520 | $604.08 | 24.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 22 | 93 | $1,395 | $390.60 | 28.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 50 | $200.00 | $59.72 | 29.9% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2022 | 47 | 34,500 | $276,000 | $87,256 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 750 | $262,500 | $82,208 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 509 | $127,250 | $41,286 | 32.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 456 | 1,544 | $38,600 | $11,583 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $32,400 | $10,812 | 33.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 160 | $44,000 | $10,760 | 24.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 51 | $25,500 | $6,185 | 24.3% |
| 99195 | Drawing of blood for a medical problem | Office | 2022 | 23 | 58 | $22,040 | $5,820 | 26.4% |
About Dr. Doron Weiner, MD
Dr. Doron Weiner, MD is a Hematology & Oncology healthcare provider based in Rockville Centre, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1881751634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Doron Weiner, MD has received a total of $7,051 in payments from pharmaceutical and medical device companies, with $408.31 received in 2024. These payments were reported across 331 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,516).
As a Medicare-enrolled provider, Weiner has provided services to 6,920 Medicare beneficiaries, totaling 185,404 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Rockville Centre, NY
- Active Since 01/02/2007
- Last Updated 03/09/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1881751634
Products in Payments
- KISQALI (Drug) $856.93
- OPDIVO (Biological) $828.93
- ELIQUIS (Drug) $303.43
- PIQRAY (Drug) $242.68
- VENCLEXTA (Biological) $217.98
- KEYTRUDA (Biological) $203.37
- JADENU (Drug) $200.50
- IBRANCE (Drug) $185.52
- TASIGNA (Drug) $164.79
- MEKINIST (Drug) $161.08
- IMBRUVICA (Drug) $133.64
- Bavencio (Biological) $114.52
- TECENTRIQ (Biological) $112.49
- RYDAPT (Drug) $112.07
- PROMACTA (Drug) $105.15
- XTANDI (Drug) $102.70
- ELAPRASE (Biological) $99.95
- ZYTIGA (Drug) $99.95
- SOLIRIS (Drug) $99.00
- XOSPATA (Drug) $90.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Rockville Centre
Dr. Abdul Mundia, Md, MD
Hematology & Oncology — Payments: $18,207
Hematology & Oncology $18,207
Richard Lee, Md, MD
Hematology & Oncology — Payments: $9,697
Hematology & Oncology $9,697
Valerie Kremer, M.d, M.D
Hematology & Oncology — Payments: $3,229
Hematology & Oncology $3,229
Dr. Magdy Shaaban, M.d, M.D
Hematology & Oncology — Payments: $3,091
Hematology & Oncology $3,091
Dr. Kenneth Angelino, M.d, M.D
Hematology & Oncology — Payments: $1,529
Hematology & Oncology $1,529
Leonard Kessler, Md, MD
Hematology & Oncology — Payments: $73.56
Hematology & Oncology $73.56